6th Algae World Asia,

28-29 Oct, 2013 - Bangkok, THAILAND

The Westin Grande Sukhumvit Bangkok

PLEASE CLICK HERE to view upcoming event. Information here is outdated
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner
  • Promotion Partner

“Advancing Algae with latest developments on Algae for
bioplastics, glycerol, therapeutic proteins, astaxanthin
and sustainable cosmetic ingredients”


Algae for Therapeutic Proteins


Dr. Stephen Mayfield, director of the San Diego Center for Algae Biotechnology was recently quoted in an interview saying  “There’s a tremendous opportunity to make therapeutic proteins in algae,”. “Because it’s agricultural, that means you have the ability to go to a very large scale and do it economically.”


For a long time, pharmaceutical companies have been making complex proteins at great cost and effort. And now with algae, the costs will be dropped dramatically and Triton is exploring this opportunity.


The company has just started to work on therapeutic proteins produced in algae, including the malaria vaccines, as well as anti-diarrheal proteins Hear from Dr Jason Pyle on the company’s step towards commercialising therapeutic proteins from Algae.


Algae for Astaxanthin


The global astaxanthin market is estimated to be around $250 million annually.


AlgaTechnologies, a  rapidly growing Israeli company specializing in the commercial cultivation of microalgae and a leading manufacturer of AstaPure willshare with us the cultivation of Haematococcus pluvialis, and optimising the conditions for efficient production of natural astaxanthin.


Asta Supreme on the other hand will talk about their specialized photobioreactor system that allows precise control over the growing environment, guaranteeing consistent high quality production of Astaxanthin. Sourced from their unique strain of algae cultivated in Nelson, New Zealand. 


Algae for Bioplastics


Breakthroughs in bioplastics  explored by Japanese scientists mainly from constituents extracted from Euglena, a species of microalgae. Dr Motonari Shibakami leading this research will share with us the technologies required to produce microalga-based plastics, including processes for efficient culture of Euglena and extraction of paramylon. 



Algae for Glycerol


The European Commission latest grant for the new EC Project on Glycerol production by Dunaliella to be led by Prof Dr Ami Ben Amotz together with a consortium of 10 European project partners Dr Amotz the key scientist on this project will share with us more details on bringing the project into the path of successful R&D.


6th AlgaeWorld ASIA promises latest news and advancements on Algae around the world that will impact Asia. Highlights include


  • Happenings in Thailand
  • - Update on Loxley Algae Biofuels Pilot Plant in Ratchaburi Province.


    - EnerGaia and their proprietary algae production system that makes it one of the most efficient producers of Spirulina.


  • Updates on Microalgae and macroalgae projects in Indonesia
  • Initiatives by India Oil Corporation in advancing algae based biofuels
  • Newly branded NXT Fuels ( previously known as Aquaflow Bionomic ) is now in a position to take multi-biomass feed stocks through to drop in hydrocarbon fuels on an economic basis. Hear from the CEO, Nick Gerritsen how the company has now shifted from research and development through to market execution and project development.


  • Heliae with its commitment on sustainable cosmetics will share novel based algae products for applications in the cosmetics industry


Book your seats now with huiyan@cmtsp.com.sg





Specially added to the agenda this year is a 2 hour exclusive visit to Thailand Institute of Scientific and Technological Research (TISTR) Technopolis - to tour TISTR's Algal R&D facilities including Algal Culture Collection , PBRs and outdoor cultivation systems. Scroll below for more details. The site visit on 29 Oct afternoon is optional and open to registered delegates only, so hurry book your seat now!




We made or augmented contacts that will almost certainly lead to doing business

- Seaplant.net Foundation


A good networking and knowledge gaining event for algae biofuel researchers and industries

- Aban Infrastructure Pvt Ltd


One of the most intimate scientific and R&D meetings in the field - ideal for networking and friendships

- Rhodes University


Extremely happy to attend - excellent networking opportunity

- General Atomics (GA)


Very insightful - a must-attend event for all those who wish to understand the REAL status of the algae biofuel industry

- Oilgae


Optional Site Visit to TISTR Algal R & D Facilities - 29 Oct (1330-1900hrs)

(Separately bookable & Open to registered delegates only)


Delegates will see all TISTR Algal R&D Facilities

  • Algal Culture Collection (ACC)
  • Algal products that already transferred to private sectors
  • Algal co-products developed by TISTR
  • Lab. cultivation system (Flat-plate photobioreactor & tubular photobioreactor)
  • Outdoor 200,000 L cultivation system

The tour will take 1-1.5 hours


About TISTR activities on Algae
Currently, microalgae have been widely recognized on their vital roles on sustainable development. Microalgae are photosynthetic organisms with high potential to be used as new renewable energy (NRE) feedstock for solving world's problems of global warming (by fixation of green-house gas-CO2) and energy crisis (by oil accumulation in their biomass). As NRE feedstock, various kinds of biorefinery products such as bioactive compounds, food, feed, biofertilizer, etc. can also be developed from suitable selected strains. Owing to its geographic location in tropical zone, Thailand is one of the most suitable countries for algal biomass production.


Thailand Institute of Scientific and Technological Research (TISTR) is the only research institute which conducts the integrate activities on research (R), development (D), technology transfer (TT) and service on freshwater microalgae of over 25 years. The activities of which starting from the up-stream of establishment and management of Algal Culture Collection (ACC) for service of strains to public and for screening of our own target of useful strains to the down-stream of R&D on cultivation processes at pilot-scale outdoor cultivation plant (200,000L continuous race-way ponds) for the production of biomass or other target compounds from selected algal strains. TISTR have succeeded in R, D &TT of biofertilizer, soil conditioner and food from microalgae to private sectors. In addition, it is the only institute that provides the service of algal strains, analysis of algal toxins in tap and drinking water, resistance testing of paint and constructing materials to algae and ecotoxicity testing using algae as test strains.


Recently, under the collaboration of THINK ALGAE (Thailand Collaborative Research Network on Microalgal Energy) supported by PTT Public Company, TISTR conducts integration green technology programs on oil production from microalgae with multi-disciplinary approach by using co-processes with wastes i.e. water and flue gas to reduce production cost and developing of biorefinery co-products such as feed and fertilizer for more value-added product chains to make oil production from microalgal feedstock feasible. The crude algal oil obtained from TISTR pilot plant is continuously sent to PTT Research and Technology Institute (PTT RTI) for the proper formulation of biofuel from algal oil.


Who Will You Meet Be a Sponsor or Exhibitor!
Project Developers,Technology Licensors, Investors, Researchers and Carbon Emitting Industries (cement,oil refineries,powerplants, etc.) and End-users (feedcompanies, food & beverage manufacturers, plastics/polymer, pharmaceutical companies, fertilizer companies, biofuel companies, transportation companies, etc) This event is an excellent platform to promote your organization to influential players and investors in the industry. Sponsorship opportunities available include Corporate, Exclusive luncheon & Cocktail sponsor.

Exhibition / catalogue display can be arranged upon request. Contact cynthia@cmtsp.com.sg or
(65) 6346 9130

To book your Exhibition space talk to
huiyan@cmtsp.com.sg or (65) 6346 9113 TODAY!

News Feed

Heliae’s new Commercial Algae Facility to produce high-value Nutraceutical and Personal Care Products

Posted on : 24 Oct, 2013


Heliae, a leader in development of advanced algae production technologies, recently announced the launch of operations at its first commercial facility in Gilbert, Arizona.


It’s a very crucial milestone as Heliae already has a well-established algae platform VolarisTM that combines the best of existing algae production models, utilising both sunlight and low-cost carbon feedstocks for optimised output. The Volaris platform promises to reduce capital costs, improve contamination control and increase productivity and product optionality as it is a hybrid of known phototrophic and heterotrophic models and is called mixotrophic algae production platform.


As this algae production platform can be customised, Heliae will be able to produce a variety of products and ingredients for multiple markets. To begin with, the commercial facility aims at producing high-value algae products for nutraceutical and personal care markets.


Listen to Mr. Mike Rohlfsen, Director of Business Development, Heliae Development, LLC at CMT’s 6th Algae World Asia opening in Bangkok, Thailand on 28-29 October 2013. He will enlighten the audience on ‘Bringing novel algae based products to the health and beauty industry’.


Get more details on the official webpage or contact Ms. Huiyan at huiyan@cmtsp.com.sg or Tel: +65 6346 9113.



Loxely earmarked approximately Bt 1 billion for production of algae-based biodiesel

Posted on : 09 Oct, 2013


Thailand based Loxley Public Company has recently announced that it will invest about Bt 1 billion in the production of algae-based biodiesel. The project will begin with a demonstration plant, and once that becomes successful, Loxley plans to commence construction of a pilot plant on 400 rai of land. The pilot plant is likely to begin operations within the next year.

Once fully operational, the company aims to produce approximately 90,000 kilograms of algae per day which will help in the production of about 30,000 litres of biofuel on a daily basis.


Biofuel is environment friendly. Therefore, the production of biofuel using algae is expected to consume about 180 tons of carbon dioxide per day, or about 10% of the total CO2 produced by the power plant. This implies the project is in the right path of reducing CO2 emission in the near future.


Loxely has already shown its commitment towards alternative energy development, particularly algae oil innovation, when the firm along with the Ratchaburi Electricity Generating Holding and Bangchak Petroleum signed a memorandum of understanding with the Alternative Energy Development and Efficiency Department to conduct R&D in this area last year.


Mr. Nattapon Dejvitak, VP, Business Development, LoxelyPublic Company is co-presenting a paper on ‘Loxley Algae Bio-fuel Demonstration Plant’ along with Mr. Anthony Bates, General Counsel & Director of Asia Operations, MBD Energyat the 6th Algae World Asia to be held from 28-29 October 2013.


For information about the event, please visit the event page.




Contact Ms. Huiyan at huiyan@cmtsp.com.sg or Tel: (65) 63469113.

Read more >>>

$ 5 Million Series-a-financing to boost Triton’s ongoing research and development programs

Posted on : 19 Sep, 2013


Triton Algae Innovations completed its Series-A equity financing worth $5 million recently with investment from Heliae Technology Holdings, Inc., a leader in the production of algae to create high-value products.


Triton, a path breaking startup in the field of synthetic biology, is expected to use these funds to enhance its ongoing research and development programs, including expansion of its product – PhycoLogix™ platform, that uses algae to produce novel products with advantages over traditional protein expression systems. The funding will also be used for commercialising Triton’s very first product line PhycoShield™.


Former Sapphire Energy founders Dr. Jason Pyle and Dr. Stephen Mayfield founded Triton. Dr. Mayfield is a much respected algal scientist across the world. Under his stewardship, Triton has produced PhyscoShield™ product line, more specifically Mammary Associated Amyloid (MAA) that can save millions of humans and livestock from diarrheal deaths. It’s reported that diarrhea is the prime cause for the death of nearly 2 million plus human beings and 20% of the world’s livestock. Triton plans to make MAA commercially available in 2014.


Apart from this, Triton is also doing high level research in the field of oncology to bring some solutions in the battle against cancer. Dr. Mayfield is the main scientist behind Triton’s oncology products. The therapies developed by Triton have already proven to be highly efficient in combatting cancers.


Triton is innovative in developing proteins. It produces complex proteins, enzymes, and other biologics for sectors such as agriculture, pharmaceutical, and retail markets, which marks a complete shift from the traditional platforms developed with algae.


To know more about the latest trends in the algae industry, CMT’s 6th Algae World Asia is the place to be on 28-29 October, 2013 in Bangkok, Thailand as Dr. Jason Pyle, founder and CEO of Triton is contributing a paper on Commercializing Advanced Biologics in Algae’ at the conference.


Visit the event page for more details.


For more information about the event, contact Ms Huiyan at huiyan@cmtsp.com.sg or Tel: (65) 63469113


Read more >>>